Search results for "Hydroxybutyrates"

showing 10 items of 22 documents

Electrospun poly(hydroxybutyrate) scaffolds promote engraftment of human skin equivalents via macrophage M2 polarization and angiogenesis.

2018

Human dermo-epidermal skin equivalents (DE) comprising in vitro expanded autologous keratinocytes and fibroblasts are a good option for massive burn treatment. However, the lengthy expansion time required to obtain sufficient surface to cover an extensive burn together with the challenging surgical procedure limits their clinical use. The integration of DE and biodegradable scaffolds has been proposed in an effort to enhance their mechanical properties. Here, it is shown that poly(hydroxybutyrate) electrospun scaffolds (PHB) present good biocompatibility both in vitro and in vivo and are superior to poly-epsilon-caprolactone electrospun scaffolds as a substrate for skin reconstruction. Impl…

0301 basic medicineKeratinocytesMaleBiocompatibilityAngiogenesisPolymersBiomedical EngineeringMedicine (miscellaneous)HydroxybutyratesNeovascularization PhysiologicHuman skinhuman skin xenograftBiocompatible Materials02 engineering and technologyNodMice SCIDpoly(hydroxybutyrate)Biomaterials03 medical and health sciencesIn vivoMice Inbred NODProhibitinsHuman Umbilical Vein Endothelial CellsAnimalsHumansRats WistarelectrospinningCell ProliferationSkin ArtificialTissue EngineeringTissue ScaffoldsChemistryMacrophagestechnology industry and agricultureCell PolarityCell DifferentiationM2 polarizationDermisSkin Transplantation021001 nanoscience & nanotechnologyM2 MacrophageIn vitro030104 developmental biologyskin equivalentsEpidermis0210 nano-technologyBiomedical engineeringJournal of tissue engineering and regenerative medicine
researchProduct

New waves underneath the purple strain.

2016

Summary Successful merging of chemical and biotechnological operations is essential to achieve cost‐efficient industrialization of bio‐based processes. The demonstration of the use of syngas, derived from microwave assisted pyrolysis of municipal solid waste, for the improved growth and poly‐3‐hydroxybutyrate production in Rhodospirillium rubrum, stands out as an example of the synergistic contribution of chemical engineering and applied microbiology to sustainable biomaterial manufacturing, paving the way to similar applications for other syngas derived bioproducts.

0301 basic medicineMunicipal solid wastelcsh:Biotechnology030106 microbiologyHydroxybutyratesBioengineeringRhodospirillum rubrumSolid WasteApplied Microbiology and BiotechnologyBiochemistryMicrowave assisted12. Responsible consumption03 medical and health sciencesBioproductslcsh:TP248.13-248.65Process engineeringHighlightbusiness.industryBiotechnology030104 developmental biologyBiodegradation EnvironmentalEnvironmental sciencebusinessPyrolysisSyngasBiotechnologyMicrobial biotechnology
researchProduct

Effect of gut-derived acetate on glucose turnover in man

1988

1. The effect of acetate absorbed from the gut on glucose turnover has been determined in four healthy subjects during both fasting and an intravenous glucose infusion by using [U-13C]glucose. 2. In the first part of the study, after an overnight fast, a tracer dose of [U-13C]glucose was infused at a constant rate along with an infusion of saline for 7 h. In the second part the saline infusion was replaced by glucose at 4.25 mg min−1 kg−1. In both studies 15 mmol of sodium acetate was given by mouth at 15 min intervals from the fourth to the sixth hour. Glucose turnover, respiratory quotient, metabolic rate and blood levels of acetate, 3-hydroxybutyrate, lactate, insulin, glucagon and gastr…

AdultDietary FiberGlycerolMalemedicine.medical_specialtymedicine.medical_treatmentHydroxybutyratesGastric Inhibitory PolypeptideAcetatesFatty Acids NonesterifiedCarbohydrate metabolismGlucagonAcetic acidchemistry.chemical_compoundGastric inhibitory polypeptideLipid oxidationInternal medicinemedicineHumansInsulinCarbon RadioisotopesAcetic Acid3-Hydroxybutyric AcidChemistryRespirationInsulinGeneral MedicineMetabolismCarbon DioxideGlucagonRespiratory quotientGlucoseEndocrinologyLactatesFemaleClinical Science
researchProduct

Effect of gut-derived acetate on oral glucose tolerance in man.

1988

1. Dietary fibre has a moderating impact on glucose metabolism. To test the hypothesis that this effect of fibre may be mediated by its breakdown product acetate, oral glucose tolerance tests were carried out in healthy volunteers with and without acetate. 2. Five subjects received 50 g of glucose orally while taking either acetate (15 mmol every 15 min) by mouth or chloride as control. Oral acetate made no detectable difference to glucose tolerance or to levels of free fatty acids, 3-hydroxybutyrate, lactate, insulin, glucagon and gastric inhibitory polypeptide. 3. The 50 g dose of glucose temporarily depressed acetate levels in blood. This was probably due to an interaction between glucos…

AdultDietary FiberMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentLumen (anatomy)HydroxybutyratesGastric Inhibitory PolypeptideXyloseCarbohydrate metabolismAcetatesFatty Acids NonesterifiedGlucagonchemistry.chemical_compoundGastric inhibitory polypeptideInternal medicinemedicine3-Hydroxybutyric AcidHumansInsulinGlucose tolerance testmedicine.diagnostic_test3-Hydroxybutyric AcidInsulinGeneral MedicineGlucose Tolerance TestGlucagonEndocrinologyGlucosechemistryLactatesFemaleClinical science (London, England : 1979)
researchProduct

Case report: Another death associated to γ-hydroxybutyric acid intoxication

2019

Abstract We report a fatal γ-hydroxybutyric acid (GHB) intoxication of a forty-year old man. According to an acquaintances’ statement, the deceased had drunk a beverage containing GHB approximately five hours before he was found. Postmortem GHB concentrations were determined using gas chromatography coupled to single quadrupole mass spectrometry after simple protein precipitation with methanol and derivatization with BSTFA (1% TMCS). Concentrations in body fluids and tissues of the deceased were as follows: cardiac blood 384 mg/L, femoral blood 358 mg/L, urine 864 mg/L, brain tissue 211 mg/kg, liver tissue 201 mg/kg, kidney tissue 492 mg/kg, bile 334 mg/L and gastric content 2025 mg/L. In a…

AdultMaleSubstance-Related DisordersPlastic bottleHydroxybutyratesUrineKidneyMass spectrometry01 natural sciencesGas Chromatography-Mass SpectrometryPathology and Forensic MedicineBeveragesboatsForensic Toxicology03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineBileHumansProtein precipitation030216 legal & forensic medicineDerivatizationBrain ChemistryKidneyChromatographyChemistry010401 analytical chemistryBSTFAboats.hull_materialGastrointestinal Contents0104 chemical sciencesmedicine.anatomical_structureLiverGas chromatographyLawChromatography LiquidHairForensic Science International
researchProduct

GHB related acids (dihydroxy butyric acids, glycolic acid) can help in the interpretation of post mortem GHB results.

2020

Post mortem gamma hydroxy butyric acid (GHB) concentrations should be interpreted with caution since GHB concentrations can increase after death. Post mortem concentrations after the intake of GHB ante mortem do overlap with concentration ranges in cases without known exposure to GHB and make an interpretation challenging. GHB is known to undergo intensive metabolism to related acids (glycolic acid (GA), succinic acid (SA), 2,4- and 3,4-dihydroxy butyric acid (2,4-OH-BA and 3,4-OH-BA)). GHB and these related acids were analyzed using a validated gas chromatographic mass spectrometric (GC-MS) method after liquid liquid extraction and trimethylsilylation. SA concentrations were not usable pos…

AdultMaleSubstance-Related DisordersSuccinic AcidHydroxybutyratesUrineGas Chromatography-Mass SpectrometryPathology and Forensic MedicineButyric acidchemistry.chemical_compoundForensic ToxicologyHumansGlycolic acidChromatographyMetabolismMiddle AgedMass spectrometricGlycolatesSubstance Abuse DetectionchemistrySuccinic acidPostmortem ChangesFemaleSodium OxybateLawBiomarkersForensic science international
researchProduct

In vitro production of GHB in blood and serum samples under various storage conditions

2011

Abstract The in vitro production of GHB was observed in freshly collected, untreated whole blood samples using glass BD-Vacutainers and polypropylene S-monovettes. GHB concentrations were determined daily over a period of one week and after 3, 6 and 9 weeks again. Furthermore, the GHB concentration in 40 untreated random whole blood samples stored at 4 °C for a longer period of time (10 samples 12 month, 10 samples 24 month and 20 samples 36 month) was also determined. For comparison, the in vitro production of GHB in freshly collected and prepared serum samples was observed. GHB serum concentrations were determined three times over a period of one week and once again after six weeks. Sampl…

AdultMaleTime FactorsHydroxybutyratesPoison controlIn Vitro TechniquesGas Chromatography-Mass SpectrometrySpecimen HandlingPathology and Forensic MedicineForensic ToxicologyHumansMedicineSample preparationWhole bloodChromatographybusiness.industryTemperatureForensic toxicologygamma-Hydroxybutyric acidMiddle AgedSerum samplesIn vitroAnesthesiaFemaleGas chromatography–mass spectrometrybusinessLawmedicine.drugForensic Science International
researchProduct

Detection of γ‐hydroxybutyric acid‐related acids in blood plasma and urine: Extending the detection window of an exogenous γ‐hydroxybutyric acid inta…

2021

In crimes facilitated by γ-hydroxybutyric acid (GHB) administration, the frequent occurrence of anterograde amnesia of the victims as well as the short detection window and variations of endogenous GHB concentrations complicate obtaining analytical proof of GHB administration. Because elevated endogenous organic acid concentrations have been found in the urine of patients with succinic semialdehyde deficiency (leading to accumulation of GHB in human specimens) and after GHB ingestion, we searched for an alternative way to prove GHB administration via detection of elevated organic acid concentrations in blood plasma and urine. We collected blood and urine samples from narcolepsy patients (n …

AdultMalemedicine.medical_specialtyAdolescentHydroxybutyratesPharmaceutical ScienceEndogenyUrine01 natural sciencesGas Chromatography-Mass SpectrometryAnalytical ChemistrySuccinic semialdehyde03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineBlood plasmamedicineHumansEnvironmental ChemistryIngestion030216 legal & forensic medicineSpectroscopyGlycolic acidAgedNarcolepsychemistry.chemical_classificationCreatinineChemistry010401 analytical chemistryMiddle Aged0104 chemical sciencesSubstance Abuse DetectionEndocrinologyFemaleOrganic acidDrug Testing and Analysis
researchProduct

Effects of leflunomide (HWA 486) on expression of lymphocyte activation markers

1993

Leflunomide (HWA 486), an isoxazol derivative, has been shown to be very effective in combating autoimmune diseases and transplantation rejection in a great number of animal models. The main metabolite of leflunomide, A77 1726, is a potent antiproliferative compound. To further elucidate this effect, lymphocytes of healthy human donors were cultured for 24, 48 or 72 h in the presence of PHA or immobilized anti-CD3 antibody. A77 1726 was added at concentrations between 10 and 100 microM. Flow cytometric evaluation of early activation or proliferation markers (IL-2 and transferrin receptors, respectively) showed that their expression was inhibited in a dose-dependent manner by A77 1726. Toget…

Adultmedicine.medical_specialtyAllergyToluidinesMetaboliteImmunologyHydroxybutyratesTransferrin receptorBiologyPharmacologyLymphocyte ActivationToxicologychemistry.chemical_compoundImmune systemInternal medicineNitrilesReceptors TransferrinmedicineHumansPharmacology (medical)PhytohemagglutininsLeflunomidePharmacologyAniline CompoundsAnti-Inflammatory Agents Non-SteroidalReceptors Interleukin-2Isoxazolesmedicine.diseaseRheumatologyTransplantationchemistryCrotonatesImmunologybiology.proteinAntibodyBiomarkersLeflunomidemedicine.drugAgents and Actions
researchProduct

Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

2019

Teriflunomide (TRF) and Dimethyl fumarate (DMF) are licensed drugs for relapsing-remitting Multiple Sclerosis (RRMS). We aimed to compare the rate and the time to discontinuation among persons with RRMS (pwRRMS), newly treated with TRF and DMF. A retrospective study on prospectively collected data was performed in nine tertiary MS centers, in Italy. The 24-month discontinuation rate in the two cohorts was the primary study outcome. We also assessed the time to discontinuation and reasons of therapy withdrawn. Discontinuation of TRF and DMF was defined as a gap of treatment ≥ 60 days. A cohort of 903 pwRRMS (316 on TRF and 587 on DMF) was analyzed. During 24 months of follow-up, pwRRMS on TR…

Adultmedicine.medical_specialtyDiscontinuation rateTime FactorsToluidinesPopulationHydroxybutyratesRelapsing-RemittingDimethyl fumarateMultiple sclerosis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMultiple Sclerosis Relapsing-RemittingInternal medicineTeriflunomideNitrilesTeriflunomidemedicineHumansMultiple sclerosi030212 general & internal medicineeducationRetrospective Studieseducation.field_of_studyDimethyl fumaratebusiness.industryProportional hazards modelMultiple sclerosisDimethyl fumarate; Discontinuation rate; Multiple sclerosis; Real-life; Teriflunomide; Neurology; Neurology (clinical)Real-lifeRetrospective cohort studyMiddle Agedmedicine.diseaseDiscontinuationchemistryItalyNeurologyCrotonatesCohortDimethyl fumarate; Discontinuation rate; Multiple sclerosis; Real-life; Teriflunomide; Adult; Crotonates; Dimethyl Fumarate; Follow-Up Studies; Humans; Immunosuppressive Agents; Italy; Middle Aged; Multiple Sclerosis Relapsing-Remitting; Retrospective Studies; Time Factors; ToluidinesNeurology (clinical)business030217 neurology & neurosurgeryImmunosuppressive AgentsFollow-Up Studies
researchProduct